Business Daily Media

Eisai Launches In-house Developed Anti-insomnia Drug Dayvigo (Lemborexant) In Hong Kong

  • Written by ACN Newswire - Press Releases

Eisai Launches In-house Developed Anti-insomnia Drug Dayvigo (Lemborexant) In Hong Kong

TOKYO, Jul 1, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has launched the in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep

Read more //?#

What Is A Level 2 Electrician And When To Engage One

Do you know when to hire a level 2 electrician? Knowing the qualifications of an electrician, and when one is needed, can be daunting for those wi...

Property

The Fast Track to Home Selling: A Comprehensive Guide to Quick Sales

The pace of the real estate market varies widely based on several factors, including location, property value, and current economic climates. For ma...

Property

6 Things You Need to Consider When Looking for A Company Car

Setting up a company car is a big decision and one that can have far-reaching consequences for your business, particularly if you choose the wrong o...

Business Training

5 Tips for Ensuring You Don’t buy a Dud Property

People purchase properties because of rental payments and the gradual appreciation of the property. However, there are cases where people purchase p...

Property

Strengthening information security: A vital step forward for businesses in wake of cyber attacks

In an era where cybercrime is on the rise, businesses are facing an unprecedented threat to their clients' private information. As the Australi...

Business Training

The age of uncertainty: How interesting times are making life tough for property pundits in 2023

Given the abundance of unknowns, predicting how and when the market will move has become a mug’s game. Anyone else tired of speculating about w...

Property